Publication:
Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML and loss of one p53 gene: Report of two cases and literature review

dc.contributor.authorDjordjević, Vesna (57215460423)
dc.contributor.authorFekete, Marija Denčić (36652618600)
dc.contributor.authorJovanović, Jelica (57202914654)
dc.contributor.authorVirijević, Marijana (36969618100)
dc.contributor.authorKurtović, Nada Kraguljac (36195445000)
dc.contributor.authorJaković, Ljubomir (21742748500)
dc.contributor.authorBogdanović, Andrija (6603686934)
dc.date.accessioned2025-06-12T15:30:36Z
dc.date.available2025-06-12T15:30:36Z
dc.date.issued2019
dc.description.abstractIntroduction. The isochromosome of the long arm of derivative chromosome 17, that originates from the translocation t(15;17) [ider(17)(q10)t(15;17), or ider(17q)] in acute promyelocytic leukemia (APL), is a rare chromosome aberration associated with a poor prognosis. Case report. We report the clinical and laboratory data associated with ider(17q) for two APL patients. Cytogenetic analysis of bone marrow cells in both cases showed a mosaic karyotype with the ider(17q); reverse transcription polymerase chain reaction (RT-PCR) was positive for the long (L) isoform of the retionic acid receptor alpha (PML-RARA) fusion transcript in each patient. Fluorescence in situ hybridization (FISH) analysis with the DNA probes for the PML gene on 15q24.1, and the RARA gene on 17q21.2, confirmed the extra copy of the RARA-PML fusion gene or ider(17q). Additionally, the FISH analysis with a DNA probe for the p53 gene on 17p13.1 confirmed loss of one copy of the univer sal tumor suppressor p53 in both patients. Conclusion. Both reported APL patients with ider(17q) had predominance of the clone with ider(17q) compared to those with t(15;17) and/or the normal karyotype, indicating that duplication of der(17) may provide a growth advantage allowing the relevant clone to become dominant. Moreover, as an important oncogenic event and poor prognostic factor in leukemia, loss of one gene copy of the tumor suppressor p53, may also contribute to this growth advantage. Although the clinical and prognostic significance for the patients with an ider(17q) remains unclear, cytogenetic and molecular-genetic analysis should be combined to reveal more details about this complex and rare chromosomal abnormality. © 2019 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
dc.identifier.urihttps://doi.org/10.2298/VSP170824174D
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85076908549&doi=10.2298%2fVSP170824174D&partnerID=40&md5=91baf288607865c7350561c6e71bbb6e
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/5822
dc.subjectChromosome abberations
dc.subjectGenes, p53
dc.subjectIn situ hybridization, fluorescence
dc.subjectLeukemia, myeloid
dc.subjectMortality
dc.subjectRetinoic acid receptor alpha
dc.subjectTranscription factors
dc.subjectTranslocation, genetic
dc.titleIsochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML and loss of one p53 gene: Report of two cases and literature review
dspace.entity.typePublication

Files